 |
市场调查报告书
商品编码
1812405
核子医学软体市场按类型、模式、治疗领域、部署模型、整合复杂性、定价模式、最终用户和地区划分Nuclear Medicine Software Market, By Type, By Modality, By Therapeutic Area, By Deployment Model, By Integration Complexity, By Pricing Model, By End User, By Geography |
||||||
核医软体市场预计在 2025 年价值 9.805 亿美元，预计到 2032 年将达到 18.039 亿美元，2025 年至 2032 年的复合年增长率为 9.1%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 9.805亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2020-2024 |
| 预测期间（2025-2032年）的复合年增长率： | 9.10% | 2032年预测 | 18.039亿美元 |
全球核子医学软体市场是支撑快速发展的核子医学和分子影像领域的关键技术支柱。这类专业软体涵盖全面的解决方案，旨在促进核子医学影像资料的收集、处理、分析和管理，包括 SPECT、PET 和混合显像模式。
核子医学软体在提高诊断准确性、简化工作流程和支援全球医疗机构的临床决策方面发挥着至关重要的作用。该市场涵盖各种软体类别，例如影像重建软体、定量分析工具、彙报系统和综合医院资讯管理平台。
随着医疗保健系统日益重视精准医疗和个人化治疗方法，核医软体已成为实现先进分子成像技术和放射性药物应用的基础组件。人工智慧、机器学习演算法和云端基础平台的整合正在彻底改变传统的核子医学实践，提供更佳的影像品质、更强大的自动化分析能力，并提高病患诊疗效率。
市场动态
全球核医软体市场正受到慢性疾病（尤其是癌症和心血管疾病）日益增长的发病率的驱动，这迫使医疗保健提供者寻求先进的诊断解决方案，以改善患者预后和治疗方案。 PET/CT 和 SPECT/CT 系统等混合成像技术的日益普及，需要能够整合和分析复杂多模态资料的先进软体平台，从而推动对综合核医学软体解决方案的需求。
人工智慧和机器学习技术的进步显着增强了软体功能，实现了自动化影像分析、更高的诊断准确性和更短的解读时间，吸引了追求营运效率和临床卓越的医疗机构。然而，市场也面临着许多限制因素，例如与先进核医学软体系统相关的高昂实施成本，这可能会给预算有限的医疗机构带来巨大压力，尤其是在成本敏感性仍然是关键考虑因素的新兴市场。此外，软体与现有医院资讯系统整合的复杂性以及法规遵循要求也带来了实施挑战，这可能会延迟部署时间表并增加营运开销。
缺乏能够有效运用先进软体平台的熟练核医专业人员也限制了市场成长，因为培训和专业知识不足会限制软体的采用和投资收益。儘管存在这些挑战，但随着核医学在精准医疗和治疗诊断学的应用不断扩大，巨大的机会正在涌现，软体平台可以支援个人化治疗方法和放射性药物治疗监测。人们日益关注基于价值的医疗保健服务模式，这为软体供应商创造了机会，使他们能够开发出能够在诊断效率、患者吞吐量和临床结果方面实现显着改进的解决方案，从而证明投资成本的合理性，并促进其在各种医疗保健环境中的市场渗透。
本次调查的主要特点
- 本报告对全球核医软体市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
- 它还揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
- 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球核医软体市场的主要企业。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球核子医学软体市场报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员将透过用于分析全球核医软体市场的各种策略矩阵更轻鬆地做出决策。
目录
第 1 章：调查目标与先决条件
- 调查目的
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章：市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 抑制因素
- 机会
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
- 产业趋势
4. 2020-2032 年全球核子医学软体市场（按类型）
- 病患资料管理软体
- 成像和视觉化软体
- 分析和量化软体
- 临床决策支援软体
- 剂量测定软体
- 工作流程和调度软体
- 治疗计画软体
- 其他（人工智慧（AI）、分析软体等）
5. 2020-2032 年全球核医软体市场（按模式）
- 正子断层扫描（PET）
- 单光子发射电脑断层扫描（SPECT）
- 混合影像软体（PET/CT、SPECT/CT、PET/MRI）
- 其他（平面闪烁扫描、混合系统）
6. 2020-2032 年全球核医软体市场（依治疗领域）
- 肿瘤学
- 心臟病学
- 神经病学
- 内分泌学
- 胃肠病学
- 其他（整形外科、感染疾病影像等）
7. 2020-2032 年全球核医软体市场（依部署模式）
- 本地部署
- 云端基础
8. 2020-2032 年全球核医软体市场（按整合度和复杂度划分）
- 独立软体
- 整合软体解决方案
9. 全球核子医学软体市场（依定价模式），2020-2032 年
- 基于订阅的定价
- 永久许可证定价
- 基于使用情况的定价（付费使用制）
- 免费增值或试用定价
- 定製或企业定价
10. 2020-2032 年全球核医软体市场（依最终使用者划分）
- 医院和诊所
- 诊断影像中心
- 学术和研究机构
- 製药和生物技术公司
第 11 章：2020-2032 年按地区分類的全球核子医学软体市场
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第十二章 竞争格局
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems Corporation
- Bracco Imaging SpA（via Advanced Accelerator Applications）
- Hermes Medical Solutions AB
- Segami Corporation
- MIM Software Inc.
- Mirada Medical Ltd.
- INVIA Medical Imaging Solutions
- Mediso Medical Imaging Systems
- Nuclear Diagnostics AB
- Sofie Biosciences Inc.
- PMOD Technologies LLC
- Xeleris
第十三章 分析师建议
- 机会
- 分析师观点
- Coherent Opportunity Map
第十四章参考文献与调查方法
- 参考
- 调查方法
- 关于 Coherent Market Insights
Nuclear Medicine Software Market is estimated to be valued at USD 980.5 Mn in 2025 and is expected to reach USD 1,803.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 980.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.10% | 2032 Value Projection: | USD 1,803.9 Mn |
The global nuclear medicine software market represents a critical technological backbone supporting the rapidly evolving field of nuclear medicine and molecular imaging. This specialized software encompasses comprehensive solutions designed to facilitate the acquisition, processing, analysis, and management of nuclear medical imaging data, including SPECT, PET, and hybrid imaging modalities.
Nuclear medicine software plays an indispensable role in enhancing diagnostic accuracy, streamlining workflow efficiency, and supporting clinical decision-making across healthcare institutions worldwide. The market encompasses various software categories including image reconstruction software, quantitative analysis tools, reporting systems, and integrated hospital information management platforms.
As healthcare systems increasingly prioritize precision medicine and personalized treatment approaches, nuclear medicine software has emerged as a fundamental component enabling advanced molecular imaging techniques and radiopharmaceutical applications. The integration of artificial intelligence, machine learning algorithms, and cloud-based platforms has revolutionized traditional nuclear medicine practices, offering enhanced image quality, automated analysis capabilities, and improved patient throughput.
Market Dynamics
The global nuclear medicine software market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, with the increasing prevalence of chronic diseases, particularly cancer and cardiovascular disorders, serving as a primary catalyst for market expansion as healthcare providers seek advanced diagnostic solutions to improve patient outcomes and treatment planning. The growing adoption of hybrid imaging technologies, including PET/CT and SPECT/CT systems, necessitates sophisticated software platforms capable of handling complex multi-modal data integration and analysis, thereby driving demand for comprehensive nuclear medicine software solutions.
Technological advancements in artificial intelligence and machine learning are significantly enhancing software capabilities, enabling automated image analysis, improved diagnostic accuracy, and reduced interpretation time, which attracts healthcare institutions seeking operational efficiency and clinical excellence. However, the market faces notable restraints including substantial implementation costs associated with advanced nuclear medicine software systems, which can burden healthcare facilities with limited budgets, particularly in emerging markets where cost-sensitivity remains a critical consideration. Additionally, the complexity of software integration with existing hospital information systems and regulatory compliance requirements create implementation challenges that may delay adoption timelines and increase operational overhead.
The shortage of skilled nuclear medicine professionals capable of effectively utilizing advanced software platforms also constrains market growth, as inadequate training and expertise can limit software utilization and return on investment. Despite these challenges, significant opportunities emerge through the expanding applications of nuclear medicine in precision medicine and theranostics, where software platforms can support personalized treatment approaches and radiopharmaceutical therapy monitoring. The increasing focus on value-based healthcare delivery models creates opportunities for software vendors to develop solutions that demonstrate measurable improvements in diagnostic efficiency, patient throughput, and clinical outcomes, thereby justifying investment costs and driving market penetration across diverse healthcare settings.
Key Features of the Study
- This report provides in-depth analysis of the global nuclear medicine software market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global nuclear medicine software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems Corporation, Bracco Imaging S.p.A. (via Advanced Accelerator Applications), Hermes Medical Solutions AB, Segami Corporation, MIM Software Inc., Mirada Medical Ltd., INVIA Medical Imaging Solutions, Mediso Medical Imaging Systems, Nuclear Diagnostics AB, Sofie Biosciences Inc., PMOD Technologies LLC, and Xeleris
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global nuclear medicine software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine software market
Market Segmentation
- Type Insights (Revenue, USD Mn, 2020 - 2032)
- Patient Data Management Software
- Imaging and Visualization Software
- Analysis and Quantification Software
- Clinical Decision Support Software
- Dosimetry Software
- Workflow and Scheduling Software
- Treatment Planning Software
- Others (Artificial Intelligence (AI) and Analytics Software, etc.)
- Modality Insights (Revenue, USD Mn, 2020 - 2032)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Others (Planar Scintigraphy, hybrid systems)
- Therapeutic Area Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Gastroenterology
- Others (Orthopedics, Infectious disease imaging, etc.)
- Deployment Model Insights (Revenue, USD Mn, 2020 - 2032)
- On-Premise
- Cloud-Based
- Integration Complexity Insights (Revenue, USD Mn, 2020 - 2032)
- Standalone Software
- Integrated Software Solutions
- Pricing Model Insights (Revenue, USD Mn, 2020 - 2032)
- Subscription-based Pricing
- Perpetual License Pricing
- Usage-based Pricing (pay-per-use)
- Freemium or Trial-based Pricing
- Customized or Enterprise Pricing
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems Corporation
- Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Hermes Medical Solutions AB
- Segami Corporation
- MIM Software Inc.
- Mirada Medical Ltd.
- INVIA Medical Imaging Solutions
- Mediso Medical Imaging Systems
- Nuclear Diagnostics AB
- Sofie Biosciences Inc.
- PMOD Technologies LLC
- Xeleris
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Nuclear Medicine Software Market, By Type
- Global Nuclear Medicine Software Market, By Modality
- Global Nuclear Medicine Software Market, By Therapeutic Area
- Global Nuclear Medicine Software Market, By Deployment Model
- Global Nuclear Medicine Software Market, By Integration Complexity
- Global Nuclear Medicine Software Market, By Pricing Model
- Global Nuclear Medicine Software Market, By End User
- Global Nuclear Medicine Software Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Nuclear Medicine Software Market, By Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Patient Data Management Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Imaging and Visualization Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Analysis and Quantification Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical Decision Support Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Dosimetry Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Workflow and Scheduling Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Treatment Planning Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (Artificial Intelligence (AI) and Analytics Software, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Nuclear Medicine Software Market, By Modality, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (Planar Scintigraphy, hybrid systems)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Nuclear Medicine Software Market, By Therapeutic Area, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (Orthopedics, Infectious disease imaging, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Nuclear Medicine Software Market, By Deployment Model, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Nuclear Medicine Software Market, By Integration Complexity, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Standalone Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Integrated Software Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Nuclear Medicine Software Market, By Pricing Model, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Subscription-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Perpetual License Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Usage-based Pricing (pay-per-use)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Freemium or Trial-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Customized or Enterprise Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global Nuclear Medicine Software Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
11. Global Nuclear Medicine Software Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hermes Medical Solutions AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Segami Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MIM Software Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mirada Medical Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- INVIA Medical Imaging Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mediso Medical Imaging Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nuclear Diagnostics AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sofie Biosciences Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PMOD Technologies LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Xeleris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
核医设备市场-全球及区域分析：按应用、最终用户及区域-分析与预测（2025-2035年）
核医市场按产品类型、给药方式、用途、应用和最终用户划分－2025-2030 年全球预测核子医学软体市场按产品类型、工作流程、整合、功能、部署模式、应用程式和最终用户划分—2025-2030 年全球预测
全球核能药局市场
全球核子医学设备市场（按系统类型、治疗领域、尺寸、最终用户和地区划分）- 预测至 2030 年
全球核子医学软体市场（按软体、应用、疾病、最终用户和地区划分）- 预测至 2030 年
核子医学市场：按类型、应用程式、最终用户和地区划分
2026 年至 2032 年核医市场类型、应用、最终用户和地区分析核子医学市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2025 年至 2030 年
2025年全球核子医学设备市场报告